Diagnostic evaluation of patients with suspected haemophagocytic lymphohistiocytosis
- 4 December 2012
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 160 (3), 275-287
- https://doi.org/10.1111/bjh.12138
Abstract
Haemophagocytic lymphohistiocytosis (HLH) is a life-threatening hyperinflammatory syndrome characterized by severely disturbed immune homeostasis. It can affect all age groups. Diagnostic evaluation of the patient with suspected HLH has to address three main questions: (i) does the patient have HLH? There is no simple diagnostic test, but a number of clinical and laboratory criteria define this clinical syndrome. (ii) Can a trigger be identified? A variety of infections, malignant or autoimmune diseases can contribute to the disturbed immune homeostasis with important consequences for treatment. (iii) Does the patient suffer from a genetic disease predisposing to HLH? Recent advances in the understanding of the genetic and pathophysiological basis of HLH have enabled a better and more rapid answer to this question, which is relevant for prognosis and the decision to perform haematopoietic stem cell transplantation. This review summarizes the current diagnostic approach to the patient with HLH.This publication has 98 references indexed in Scilit:
- CD27 deficiency is associated with combined immunodeficiency and persistent symptomatic EBV viremiaJournal of Allergy and Clinical Immunology, 2012
- Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocolBlood, 2011
- Risk factors for early death in children with haemophagocytic lymphohistiocytosisActa Paediatrica, 2011
- How I treat hemophagocytic lymphohistiocytosisBlood, 2011
- Using flow cytometry to screen patients for X-linked lymphoproliferative disease due to SAP deficiency and XIAP deficiencyJournal of Immunological Methods, 2010
- Rate of decline of ferritin in patients with hemophagocytic lymphohistiocytosis as a prognostic variable for mortalityPediatric Blood & Cancer, 2010
- Munc18-2 deficiency causes familial hemophagocytic lymphohistiocytosis type 5 and impairs cytotoxic granule exocytosis in patient NK cellsJCI Insight, 2009
- Familial Hemophagocytic Lymphohistiocytosis Type 5 (FHL-5) Is Caused by Mutations in Munc18-2 and Impaired Binding to Syntaxin 11American Journal of Human Genetics, 2009
- Defective cytotoxic lymphocyte degranulation in syntaxin-11–deficient familial hemophagocytic lymphohistiocytosis 4 (FHL4) patientsBlood, 2007
- Spectrum and clinical implications of syntaxin 11 gene mutations in familial haemophagocytic lymphohistiocytosis: association with disease-free remissions and haematopoietic malignanciesJournal of Medical Genetics, 2005